NO20010981L - Stafylokokkale immunoterapeutika via donorseleksjon og donorstimulering - Google Patents

Stafylokokkale immunoterapeutika via donorseleksjon og donorstimulering

Info

Publication number
NO20010981L
NO20010981L NO20010981A NO20010981A NO20010981L NO 20010981 L NO20010981 L NO 20010981L NO 20010981 A NO20010981 A NO 20010981A NO 20010981 A NO20010981 A NO 20010981A NO 20010981 L NO20010981 L NO 20010981L
Authority
NO
Norway
Prior art keywords
donor
plasma pool
adhesins
proteins
titers
Prior art date
Application number
NO20010981A
Other languages
English (en)
Norwegian (no)
Other versions
NO20010981D0 (no
Inventor
Joseph M Patti
Timothy James Foster
Magnus Hook
Original Assignee
Inhibitex Inc
Texas A & M Univ Sys
Trinity College Dublin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inhibitex Inc, Texas A & M Univ Sys, Trinity College Dublin filed Critical Inhibitex Inc
Publication of NO20010981D0 publication Critical patent/NO20010981D0/no
Publication of NO20010981L publication Critical patent/NO20010981L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
NO20010981A 1998-08-31 2001-02-27 Stafylokokkale immunoterapeutika via donorseleksjon og donorstimulering NO20010981L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9844998P 1998-08-31 1998-08-31
PCT/US1999/019729 WO2000012132A1 (fr) 1998-08-31 1999-08-31 Procede d'immunotherapie contre les infections staphylococciques comprenant la selection des donneurs et la stimulation des donneurs

Publications (2)

Publication Number Publication Date
NO20010981D0 NO20010981D0 (no) 2001-02-27
NO20010981L true NO20010981L (no) 2001-04-26

Family

ID=22269332

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010981A NO20010981L (no) 1998-08-31 2001-02-27 Stafylokokkale immunoterapeutika via donorseleksjon og donorstimulering

Country Status (6)

Country Link
EP (1) EP1121149A4 (fr)
JP (1) JP2002523474A (fr)
AU (1) AU762978B2 (fr)
CA (1) CA2341177A1 (fr)
NO (1) NO20010981L (fr)
WO (1) WO2000012132A1 (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7128919B2 (en) * 2000-08-08 2006-10-31 St. Jude Children's Research Hospital Group B streptococcus polypeptides nucleic acids and therapeutic compositions and vaccines thereof
US7892552B2 (en) 2001-08-08 2011-02-22 University Of Utah Research Foundation Group B Streptococcus polypeptides nucleic acids and therapeutic compositions and vaccines thereof
IL157041A0 (en) 2001-01-26 2004-02-08 Inhibitex Inc Monoclonal antibodies to the clfa protein and method of use in treating and preventing infections
EP2339344A1 (fr) * 2001-06-15 2011-06-29 Inhibitex, Inc. Anticorps monoclonaux et polyclonaux à réaction croisée qui reconnaissent des protéines de surface de staphylocoques à coagulase négative et de staphylocoques dores
EP1804833A2 (fr) 2004-09-22 2007-07-11 GlaxoSmithKline Biologicals SA Compositions immunogenes de staphylocoques
GB0526038D0 (en) 2005-12-21 2006-02-01 Glaxosmithkline Biolog Sa Immunogenic composition
EP2476433A1 (fr) 2006-03-30 2012-07-18 GlaxoSmithKline Biologicals S.A. Composition immunogène
US9181329B2 (en) 2007-08-31 2015-11-10 The University Of Chicago Methods and compositions related to immunizing against Staphylococcal lung diseases and conditions
EP2666784B1 (fr) 2007-08-31 2017-04-05 University Of Chicago Méthodes et compositions associées à l'immunisation contre des maladies et d'affections pulmonaires staphylococciques
US8758765B2 (en) 2008-07-29 2014-06-24 The University Of Chicago Compositions and methods related to Staphylococcal bacterium proteins
WO2010085590A1 (fr) 2009-01-23 2010-07-29 Biosynexus Incorporated Anticorps opsoniques et protecteurs spécifiques de bactéries à gram positifs à acide lipotéichoïque
AU2010271116B2 (en) 2009-04-03 2015-08-13 University Of Chicago Compositions and methods related to Protein A (SpA) variants
NZ616921A (en) 2009-07-15 2015-06-26 Genentech Inc Gram-positive bacteria specific binding compounds
GB0913680D0 (en) 2009-08-05 2009-09-16 Glaxosmithkline Biolog Sa Immunogenic composition
GB0913681D0 (en) 2009-08-05 2009-09-16 Glaxosmithkline Biolog Sa Immunogenic composition
US8808699B2 (en) 2010-04-05 2014-08-19 The University Of Chicago Compositions and methods related to protein A (SpA) antibodies as an enhancer of immune response
ES2655701T3 (es) 2010-07-02 2018-02-21 The University Of Chicago Composiciones y métodos relacionados con variantes de la proteína A (SpA)
JP5793194B2 (ja) * 2010-09-09 2015-10-14 ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ 感染防御ブドウ球菌抗原が関与する方法および組成物
US8945588B2 (en) 2011-05-06 2015-02-03 The University Of Chicago Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
CA2845259A1 (fr) 2011-08-15 2013-02-21 The University Of Chicago Compositions et procedes lies aux anticorps anti-proteine a du staphylocoque
ES2806945T3 (es) 2012-04-26 2021-02-19 Univ Chicago Antígenos de coagulasa estafilocócica y métodos para su uso
CA2910320A1 (fr) 2012-04-26 2013-10-31 University Of Chicago Compositions et procedes associes a des anticorps qui neutralisent l'activite coagulase dans une maladie a staphylococcus aureus
GB201310008D0 (en) 2013-06-05 2013-07-17 Glaxosmithkline Biolog Sa Immunogenic composition for use in therapy
MX2016007533A (es) 2013-12-09 2016-12-14 Univ New York Composiciones y metodos para el suministro fagocitico de agentes anti-estafilococicos.
RU2558114C1 (ru) * 2014-01-23 2015-07-27 Федеральное государственное бюджетное военное образовательное учреждение высшего профессионального образования Военно-медицинская академия им. С.М. Кирова Министерства обороны Российской Федерации (ВМедА) Способ отбора доноров для получения плазмы крови, эффективной при лечении пациентов с инфекционными заболеваниями и осложнениями после оперативных вмешательств, травм и ожогов
US9107906B1 (en) 2014-10-28 2015-08-18 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
RU2601372C2 (ru) * 2014-11-17 2016-11-10 Федеральное государственное бюджетное военное образовательное учреждение высшего профессионального образования Военно-медицинская академия им. С.М. Кирова Министерства обороны Российской Федерации (ВМедА) Способ отбора доноров крови для получения плазмы с целью лечения пациентов с инфекционными заболеваниями и осложнениями после оперативных вмешательств, травм и ожогов
MX2017007652A (es) 2014-12-10 2017-10-11 Glaxosmithkline Biologicals Sa Metodo de tratamiento.
RU2606377C1 (ru) * 2015-10-12 2017-01-10 Федеральное государственное бюджетное военное образовательное учреждение высшего профессионального образования Военно-медицинская академия им. С.М. Кирова Министерства обороны Российской Федерации (ВМедА) Способ отбора образцов крови доноров с повышенным содержанием дефензинов для получения моноиммунной плазмы крови
US11214600B2 (en) 2016-02-12 2022-01-04 The University Of Chicago Compositions and methods related to antibodies that neutralize coagulase activity during Staphylococcus aureus disease
RU2665170C2 (ru) * 2016-12-08 2018-08-28 Федеральное государственное бюджетное военное образовательное учреждение высшего образования Военно-медицинская академия им. С.М. Кирова Министерства обороны Российской Федерации (ВМедА) Способ лечения пациентов с осложнениями внутригоспитальными инфекциями
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
WO2021067785A1 (fr) 2019-10-02 2021-04-08 Janssen Vaccines & Prevention B.V Peptides de staphylococcus et procédés d'utilisation
CN111909279B (zh) * 2020-08-14 2022-06-24 石河子大学 一种金黄色葡萄球菌与无乳链球菌免疫原融合表达及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK219084D0 (da) * 1984-05-02 1984-05-02 Frederik Carl Peter Lindberg Antigen
ES2198405T3 (es) * 1991-11-22 2004-02-01 Nabi Biopharmaceuticals Antigenos de superficie de tipo i asociados a staphylococcus epidermis.
EP0680337A4 (fr) * 1993-01-12 1997-07-30 Anthony George Gristina Procedes et compositions pour application directe a forte concentration d'anticorps, produisant une immunite passive.
US5648240A (en) * 1994-05-24 1997-07-15 Texas A&M University MHC II analog from Staphylococcus aureus
JP2001505061A (ja) * 1996-02-29 2001-04-17 ワシントン ユニヴァーシティ バクテリア性エラスチン結合タンパク、これをコードする核酸配列およびこれを使用した診断並びに治療方法
CA2255669A1 (fr) * 1996-05-16 1997-11-20 The Texas A & M University System Compositions de proteine de liaison du collagene et procedes d'utilisation
SE9602496D0 (sv) * 1996-06-20 1996-06-20 Bengt Guss Method and means for producing a fibrinogen binding protein and its use in biotechnology
CA2277793A1 (fr) * 1997-01-21 1998-07-23 The Texas A & M University System Compositions de proteines se liant a la fibronectine et leurs procedes d'utilisation
CA2310217A1 (fr) * 1997-11-26 1999-06-03 Inhibitex, Inc. Proteines liant la matrice extracellulaire issues du staphilococcus aureus
ATE422368T1 (de) * 1998-08-31 2009-02-15 Inhibitex Inc Multikomponenten impfstoffe gegen staphylococcus aureus

Also Published As

Publication number Publication date
NO20010981D0 (no) 2001-02-27
AU762978B2 (en) 2003-07-10
CA2341177A1 (fr) 2000-03-09
AU5696699A (en) 2000-03-21
JP2002523474A (ja) 2002-07-30
EP1121149A1 (fr) 2001-08-08
EP1121149A4 (fr) 2002-03-20
WO2000012132A1 (fr) 2000-03-09

Similar Documents

Publication Publication Date Title
NO20010981L (no) Stafylokokkale immunoterapeutika via donorseleksjon og donorstimulering
Fattom et al. Efficacy profile of a bivalent S taphylococcus aureus glycoconjugated vaccine in adults on hemodialysis: Phase III randomized study
DK2244722T3 (en) Treating microbial infections
BR0207068A (pt) Anticorpo monoclonal para a protéina clfa, anti-soro isolado, anticorpo isolado e anticorpo humanizado contendo o referido anticorpo, kit diagnóstico compreendendo o referido anticorpo, método para diagnóstico de uma infecção por s.aureus, composição farmacêutica para o tratamento ou prevenção da referida infecção, método para indução de de uma resposta imunológica, método para identificação de anticorpos monoclonais para a protéina clfa e fragmento ativo isolado a partir do domìnio a da protéina clfa do s.aureus
BRPI0515516B1 (pt) Immunogenic composition, vaccine, method of manufacturing a vaccine, and, use of immunogenic composition.
JP6773830B2 (ja) 治療において使用するための免疫原性組成物
Shaughnessy et al. Fusion protein comprising factor H domains 6 and 7 and human IgG1 Fc as an antibacterial immunotherapeutic
EP2453915B1 (fr) Traitement d infections
US9920113B2 (en) Antibody binding microbial heparin binding motif to retard or prevent microbial biofilm formation on implanted medical devices
Hartmann et al. Immunization with B rugia malayi Hsp70 protects mice against L itomosoides sigmodontis challenge infection
JPS6230729A (ja) 多価高度免疫グロブリン製剤およびその製法
Kelly Immunotherapy against antibiotic-resistant bacteria: the Russian experience with an antistaphylococcal hyperimmune plasmaand immunoglobulin
DK143249B (da) Fremgangsmaade til fremstilling af en vandig gamma-globulinoploesning til terapeutisk anvendelse mod infektioner af pseudomonas aeruginosa
RU2470664C2 (ru) Способ получения иммуноглобулина для внутривенного введения, обогащенного иммуноглобулином м, и препарат, полученный этим способом
Hofmann et al. Protection of mice against tick-borne encephalitis by different classes of immunoglobulins
Schönermarck et al. Effect of apheresis for ABO and HLA desensitization on anti‐measles antibody titers in renal transplantation
Shevtsov et al. Serum immunobiological preparation for prophylaxis and therapy of anthrax
US20050103712A1 (en) Methods and devices for treating severe peripheral bacterial infections
US20170281744A1 (en) Method of treatment
Sanjari Evaluation of a Pentavalent Vaccine Against Staphylococcus aureus in a Murine Model of Chronic Peritoneal Abscess
WO2007005715A2 (fr) Anticorps staphylococciques a reaction croisee avec des antigenes fongiques
Shared Isolation and Chemical Characterization of
WO2006080867A1 (fr) Produit de stimulation de la secretion du facteur viii de coagulation sanguine

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application